Egfr
A topic on our watch list — we track its coverage across 9 domains, including Pubmed Targeted, Preprint and Industry News.
Coverage of Egfr is holding steady : 4 signals on the latest tracked day, level with its three-week baseline of 4, across 3 domains. That makes it the #223 most-covered of the 348 concerns we track.
What’s changed
- The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity. · Cancer Res · 2026-09-01
- EMB-01, an Anti-EGFR/c-MET Bispecific Antibody, in Patients with Heavily Pretreated Metastatic Colorectal Cancer From a Phase Ib/II, Open-Label, Multicenter Study. · Clin Cancer Res · 2026-08-24
- RAF/MEK Clamp Inhibition with Avutometinib and Cetuximab in RAF1 S257L-Mutated, Anti-EGFR-Refractory Metastatic Colorectal Cancer in Gaucher's disease. · Oncologist · 2026-08-19
- High-dose furmonertinib plus bevacizumab and intrathecal pemetrexed for EGFR-RAD51 fusion-positive lung adenocarcinoma with leptomeningeal metastasis: Insights from serial CSF ctDNA monitoring · European Journal of Cancer · 2026-08-16
- Reply to: “Understanding the Contribution of Anti-EGFR Reinduction to Overall Survival in the TRIPLETE Study” and “TRIPLETE But Incomplete? Accounting for Postprogression Therapy When Interpreting Overall Survival” · Journal of Clinical Oncology · 2026-08-13
- HUTCHMED Enters Exclusive Global License Agreement with GSK for HMPL-A830, First-in-Class KRAS-EGFR ATTC - Quiver Quantitative · KRAS Mutation Research (Google News) · 2026-09-03 · usually covers Kras Research
What the reporting says
It shows up alongside Colorectal Cancer (50), KRAS (27 — acquisition ×2), Braf (24 — acquisition ×2), Lung Cancer (23 — acquisition ×2), Immunotherapy (18), Her2 (15), ctDNA (9), FDA (14).
Two steps out: MSI-H (through Colorectal Cancer, 50 shared stories on the weaker link); Wang (through Colorectal Cancer, 50 shared stories on the weaker link); Zhang (through Colorectal Cancer, 50 shared stories on the weaker link); Chen (through Colorectal Cancer, 46 shared stories on the weaker link).
Tracked since Jan 1, with coverage on 58 separate days — concentrated in Oncology and Pubmed Targeted.